By Partha Ghosh, MD, Siemens Healthineers, Hoffman Estates, Illinois, USA
Clinical impact of absolute SPECT/CT quantification in theranostics and dosimetry
Major advances in SPECT/CT technology have enabled absolute quantification to be accurate and reproducible. Download the white paper and explore the clinical impact of SPECT/CT quantification in theranostics and dosimetry.
By Vijay Shah, Ph.D., Siemens Healthineers
By Rachid Fahmi, PhD and Guenther Platsch, MD, Siemens Healthineers
By Carl von Gall, MD, Vijay Shah, PhD, and Ludovic Sibille, MSc, Siemens Healthineers
By Bruce Spottiswoode, Ph.D.; Damita Thomas, M.D.
By Munir Ghesani, MD, FACNM, FACR, New York, NY, USA.
PET/CT plays an increasingly important role in the appropriate clinical setting in both initial and subsequent treatment strategies in melanoma management. Read the white paper to discover the value PET/CT imaging can have for melanoma.
By Partha Ghosh, MD, Siemens Healthineers
Skeletal scintigraphy has been a mainstay of nuclear medicine for decades. Take a closer look at clinical examples that illustrate the image quality levels in bone scintigraphy made possible using xSPECT Bone™ technology in this SPECT/CT clinical white paper.
By A. Hans Vija, PhD; Carl von Gall, MD; and Partha Ghosh, MD, Siemens Healthineers
The introduction of xSPECT Quant™ for absolute quantification of 177Lu, 111In, and 123I is a major step toward implementation and expansion of standardized evidence-based medicine in the realm of radionuclide imaging. Download the white paper to learn more about Siemens Healthineers’ xSPECT Quant technology.
By A. Hans Vija, PhD, Siemens Healthineers
In 2013, Siemens introduced xSPECT™, which represents a more complete integration of SPECT and CT data. Download the white paper to understand the fundamentals of xSPECT reconstruction for SPECT/CT and its advantages over traditional approaches.
By Jackson Kiser, MD, Molecular Imaging and Therapy Consultants of Virginia
Discover how transitioning from a mobile PET scanner—an ideal way to introduce technology to facilities interested in exploring the potential for PET imaging— to a fixed scanner can benefit in a hospital setting.
By Partha Ghosh, MD, Siemens Healthineers; and Dimitre Hristov, PhD, Department of Radiation Oncology, Stanford University
Learn how PET/CT provides metabolic and morphological information, which has a major impact on the evaluation and therapy planning of primary and recurrent lung tumors.
By Kristin Schmiedehausen, MD
PET/CT is a powerful modality used to assess cervical cancer, particularly in tumors of stage IB and beyond. As the topic of cervical cancer and PET/CT has been increasing in interest in the last years, stay informed on the status of the disease, guidelines, and reimbursement opportunities by reading the following white paper.
By Kristin Schmiedehausen, MD
Explore the role of PET/CT in imaging high-risk patients (such as those with an elevated PSA level or Gleason score) for skeletal metastases. Read the white paper to review PET's role on therapy decisions during initial diagnosis and therapy monitoring.